讯飞医疗科技 02506Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name讯飞医疗科技
Stock Code02506
Company Full Name讯飞医疗科技
Industry軟件服務
Principal Activities公司是一家人工智能賦能的醫療解決方案提供商。
Listing Date2024-12-30
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市西城區廣安門內大街167號
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttps://www.iflyhealth.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo
// Offering Information //
Offering Mechanism 未知
Clawback TiersNo data
Prospectus Date2024-12-18
Offer PriceHK$ 82.80 / shares
Offer Price RangeFinal offer price only, no range
Lot Size50 shares
Entry ThresholdHK$ 4,140
Par ValueNo data
Global Offering Shares7,035,550
HK Public Offering Shares— (0.0%)
International Placing Shares6,331,950 (90.0%)
Offer RatioNo data
Total Shares Post-IPONo data
Total Global Offering SizeHK$ 582,543,540
Public Offering SizeHK$ — (0.0%)
Oversubscription Multiple3.7x
Valid Applications3,136
Accepted Applications2,822
ReallocationNo
Total Funds RaisedHK$ 58,258,080
Greenshoe (Over-allotment Option)No
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
Pre-IPO Valuation (Last Round)No data
P/E Ratio-63.04
Profit/Loss StatusNo data
Period-End Cash BalanceNo data
Listing Expenses~HK$ 75,400,000
Listing Expenses / Funds RaisedNo data
Total Pre-IPO InvestmentNo data
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 89.75
First Day Change5.07%
First Day Volume520446.0
First Day Turnover45709400.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、約32.4%(即164.0百萬港元)將用于投資研發,以不斷加強公司的核心能力; 2、約26.6%(即135.0百萬港元)將用于通過升級現有產品及開發新產品進一步豐富公司的產品及服務; 3、約24.7%(即125.1百萬港元)將用于加強商業化能力并擴展公司的服務網絡; 4、約6.4%(即32.3百萬港元)將用于收購可能與公司現有產能產生協同效應的公司; 5、約10.0%(即50.7百萬港元)將用于營運資金及其他一般企業用途。
// Underwriting Syndicate //
联席保荐人 (3)
华泰金融控股(香港)有限公司 广发融资(香港)有限公司 建银国际金融有限公司
保荐人兼整体协调人 (1)
华泰金融控股(香港)有限公司
整体协调人 (3)
华泰金融控股(香港)有限公司 广发证券(香港)经纪有限公司 建银国际金融有限公司
联席全球协调人 (3)
华泰金融控股(香港)有限公司 广发证券(香港)经纪有限公司 建银国际金融有限公司
联席账簿管理人 (9)
华泰金融控股(香港)有限公司 广发证券(香港)经纪有限公司 建银国际金融有限公司 工银国际证券有限公司 浦银国际融资有限公司 民银证券有限公司 农银国际融资有限公司 中国银河国际证券(香港)有限公司 TradeGo Markets Limited
联席牵头经办人 (10)
华泰金融控股(香港)有限公司 广发证券(香港)经纪有限公司 建银国际金融有限公司 工银国际证券有限公司 浦银国际融资有限公司 民银证券有限公司 农银国际证券有限公司 中国银河国际证券(香港)有限公司 TradeGo Markets Limited 宏智证券(香港)有限公司
资本市场中介人 (11)
华泰金融控股(香港)有限公司 广发证券(香港)经纪有限公司 建银国际金融有限公司 工银国际证券有限公司 浦银国际融资有限公司 民银证券有限公司 农银国际融资有限公司 农银国际证券有限公司 中国银河国际证券(香港)有限公司 TradeGo Markets Limited 宏智证券(香港)有限公司
// Service Providers //
RoleInstitution
本公司法律顾问 高伟绅律师事务所
上海澄明则正律师事务所
Pillsbury Winthrop Shaw Pittman LLP
保荐人/包销商法律顾问 欧华律师事务所
金杜律师事务所
核数师兼申报会计师 德勤•关黄陈方会计师行
行业顾问 弗若斯特沙利文(北京)咨询有限公司上海分公司
合规顾问 新百利融资有限公司
收款银行 招商永隆银行有限公司
// Cornerstone Investors // Allotment Results Announcement
#Investor NameShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 達安投資有限 751,700 10.68% 0.97%
2 訊醫有限公司 748,750 10.64% 0.97%
3 星群有限公司 338,150 4.81% 0.44%
// Directors & Management //
Chairman劉慶峰
Company Secretary劉偉;楊兆琳
No director data available.
// Major Shareholders //
Major Shareholders & Holdings科大訊飛股份有限公司(49.42%),合肥正升信息科技合伙企業(有限合伙)(16.11%),安徽科訊創業投資基金合伙企業(有限合伙)(14.43%)
// Allotment Benchmarks //
Pool A (Small Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
50 1,574 1,260 0.80
100 449 449 1.06
150 71 71 1.44
200 33 33 1.73
250 112 112 2.00
300 42 42 2.22
350 9 9 2.55
400 6 6 2.80
450 12 12 3.00
500 140 140 3.28
600 9 9 3.74
700 16 16 4.00
800 9 9 4.50
900 10 10 5.00
1,000 119 119 5.13
1,500 32 32 7.00
2,000 30 30 8.00
2,500 33 33 9.00
3,000 19 19 10.00
3,500 6 6 11.00
4,000 8 8 12.00
4,500 4 4 13.00
5,000 20 20 14.00
6,000 8 8 16.00
7,000 2 2 18.00
8,000 1 1 20.00
9,000 1 1 22.00
10,000 15 15 24.00
20,000 7 7 44.00
30,000 3 3 64.02
40,000 1 1 84.00
50,000 1 1 104.00
Pool B (Large Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
70,000 1 1 456.96
80,000 1 1 522.08
90,000 2 2 586.98
100,000 2 2 651.00
200,000 1 1 1300.00
351,800 1 1 2281.07
Allotment Benchmarks
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics